The U.S. Court of Appeals for the Federal Circuit overturned a ruling in favor of AngioScore in a patent infringement case between it and TriReme Medical and a pair of related companies. The court ruled that an earlier decision from the United States District Court for the Northern District of California “improperly exercised supplemental jurisdiction over state-law […]
AngioScore Inc.
FDA approves clinical trial for QT Vascular’s Chocolate Touch DCB
QT Vascular said today that it won an investigational device exemption from the FDA for a pivotal study of its Chocolate Touch drug-coated balloon. The device won the CE Mark for treating peripheral artery disease in September 2015 and in July it won approval for treating coronary artery disease. The Singapore-based company is slated to […]
Appeals court tosses $20m AngioScore win over TriReme Medical
A federal appeals court yesterday tossed AngioScore‘s $20 million win over TriReme Medical and a pair of related companies, ruling that the case never should have made it to the federal level. Just more than a year ago, Judge Yvonne Gonzalez Rogers of the U.S. District Court for Northern California ruled that AngioScore founder Eitan Konstantino violated his duties to AngioScore when […]
Appeals court reverses TriReme patent loss to AngioScore
CORRECTED July 22, 2016. This article originally transposed the patent infringement lawsuit filed by TriReme against AngioScore for a breach-of-contract lawsuit filed by AngioScore. A federal appeals court today reversed a lower court’s patent infringement ruling that went against TriReme Medical and a pair of related companies in favor of AngioScore, sending the case back to a lower court […]
TriReme, founder win AngioScore patent spat, lose bid for legal fees
AngioScore lost the patent infringement portion of its legal war with co-founder and former board member Eitan Konstantino, but won’t have to pay its opponents’ $4.8 million legal tab, a federal judge ruled this week. AngioScore, which accused Konstantino of violating his fiduciary duties when he started TriReme Medical, Quattro Vascular and QT Vascular, won a $20 million […]
QT Vascular wins stay in $20m loss to AngioScore
QT Vascular and a pair of related companies last week won a stay in their $20 million loss to AngioScore so their appeal can proceed. In July, a federal judge ruled that founder Eitan Konstantino violated his duties to AngioScore when he started QT Vascular, TriReme Medical and Quattro Vascular. AngioScore, which Spectranetics (NSDQ:SPNC) acquired last year for $230 million, accused Konstantino of breaching his fiduciary duties […]
TriReme appeals $20m loss to AngioScore
TriReme Medical and a pair of related companies are appealing a $20 million loss to AngioScore after a federal judge ruled that founder Eitan Konstantino violated his duties to AngioScore when he started TriReme, Quattro Vascular and QT Vascular. AngioScore, which Spectranetics (NSDQ:SPNC) acquired last year for $230 million, accused Konstantino of breaching his fiduciary duties to AngioScore by developing the TriReme’s Chocolate balloon catheter, […]
UPDATE: Spectranetics’ AngioScore wins $20m from Trireme, founder Konstantino
UDATED July 8, 2015, with comment from QT Vascular, stock performance. AngioScore last week won a $20 million judgment against co-founder and former board member Eitan Konstantino, after a federal judge ruled that Konstantino violated his duties to AngioScore when he started TriReme Medical, Quattro Vascular and QT Vascular. AngioScore, which Spectranetics (NSDQ:SPNC) acquired last year for […]
Spectranetics closes $230M AngioScore buy
Colorado-based Spectranetics (NSDQ:SPNC) announced today that it consummated its $230 million acquisition of California-based AngioScore, adding that milestones payments are also on the forecast.
MGH researchers gain $30 million grant to build brain implants for treating mental illness | Medtech funding for the week of May 26, 2014
M&A: Spectranetics prepares $200M offering to fund $230M AngioScore bid
